Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Drops By 26.4%

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 100,200 shares, a decline of 26.4% from the October 15th total of 136,100 shares. Approximately 16.0% of the shares of the company are short sold. Based on an average trading volume of 472,700 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Separately, LADENBURG THALM/SH SH began coverage on Autonomix Medical in a research note on Tuesday, September 3rd. They issued a “buy” rating and a $28.00 target price for the company.

Autonomix Medical Trading Up 1.3 %

NASDAQ:AMIX traded up $0.12 during trading hours on Friday, hitting $9.69. The company had a trading volume of 13,767 shares, compared to its average volume of 225,310. The company has a market capitalization of $11.14 million and a PE ratio of -0.61. The company has a debt-to-equity ratio of 0.36, a current ratio of 4.26 and a quick ratio of 9.27. The stock has a 50-day moving average price of $12.29 and a 200 day moving average price of $22.85. Autonomix Medical has a 52 week low of $7.51 and a 52 week high of $152.00.

Autonomix Medical (NASDAQ:AMIX) last released its earnings results on Tuesday, August 13th. The company reported ($2.80) earnings per share (EPS) for the quarter. On average, equities research analysts predict that Autonomix Medical will post -10 EPS for the current fiscal year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.